Goldman Sachs Group Inc Astrazeneca PLC Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,286,115 shares of AZN stock, worth $959 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
12,286,115
Previous 11,533,478 6.53%
Holding current value
$959 Million
Previous $777 Million 7.16%
% of portfolio
0.15%
Previous 0.15%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$61.03 - $69.57 $45.9 Million - $52.4 Million
752,637 Added 6.53%
12,286,115 $832 Million
Q4 2023

Feb 13, 2024
BUY
$61.89 - $69.28 $27.9 Million - $31.2 Million
449,999 Added 4.06%
11,533,478 $777 Million
Q3 2023

May 14, 2024
SELL
$64.85 - $71.7 $29.2 Million - $32.3 Million
-449,999 Reduced 3.9%
11,083,479 $751 Million
Q3 2023

Nov 14, 2023
BUY
$64.85 - $71.7 $31.4 Million - $34.7 Million
483,775 Added 4.56%
11,083,479 $751 Million
Q2 2023

May 14, 2024
BUY
$69.91 - $75.81 $91.8 Million - $99.6 Million
1,313,594 Added 14.15%
10,599,704 $759 Million
Q2 2023

Aug 14, 2023
BUY
$69.91 - $75.81 $91.8 Million - $99.6 Million
1,313,594 Added 14.15%
10,599,704 $759 Million
Q1 2023

May 14, 2024
BUY
$63.15 - $71.6 $96.9 Million - $110 Million
1,534,625 Added 19.8%
9,286,110 $645 Million
Q1 2023

May 11, 2023
BUY
$63.15 - $71.6 $96.9 Million - $110 Million
1,534,625 Added 19.8%
9,286,110 $645 Million
Q4 2022

May 14, 2024
BUY
$54.21 - $70.44 $54.3 Million - $70.5 Million
1,000,884 Added 14.83%
7,751,485 $526 Million
Q4 2022

Feb 13, 2023
BUY
$54.21 - $70.44 $54.3 Million - $70.5 Million
1,000,884 Added 14.83%
7,751,485 $526 Million
Q3 2022

May 14, 2024
BUY
$53.02 - $135.75 $18.3 Million - $46.9 Million
345,216 Added 5.39%
6,750,601 $370 Million
Q3 2022

Nov 10, 2022
BUY
$53.02 - $135.75 $18.3 Million - $46.9 Million
345,216 Added 5.39%
6,750,601 $370 Million
Q2 2022

May 14, 2024
SELL
$59.26 - $71.14 $304 Million - $365 Million
-5,128,093 Reduced 44.46%
6,405,385 $423 Million
Q2 2022

Aug 15, 2022
SELL
$59.26 - $71.14 $48.9 Million - $58.7 Million
-825,637 Reduced 11.42%
6,405,385 $423 Million
Q1 2022

May 16, 2022
BUY
$55.72 - $67.12 $52.9 Million - $63.7 Million
948,560 Added 15.1%
7,231,022 $480 Million
Q4 2021

Feb 14, 2022
SELL
$54.02 - $63.83 $283 Million - $335 Million
-5,241,096 Reduced 45.48%
6,282,462 $366 Million
Q3 2021

Nov 10, 2021
BUY
$55.56 - $60.79 $640 Million - $701 Million
11,523,558 New
11,523,558 $692 Million

Others Institutions Holding AZN

# of Institutions
1,244
Shares Held
477M
Call Options Held
5.99M
Put Options Held
5.24M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $242B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email